Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)

NCT00408278 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Acute Promyelocytic Leukemia

Interventions

DRUG: ATRA
DRUG: Idarubicina
DRUG: Mitoxantrone
DRUG: ARA-C

Sponsor

PETHEMA Foundation